Erschienen in:
18.05.2019 | Hepatitis C (H Vargas and S Flamm, Section Editors)
Hepatitis C-Positive Organs for Liver and Kidney Transplantation—Emerging Data and Current Management Strategies
verfasst von:
Blanca C. Lizaola-Mayo, Hugo E. Vargas, David M. Chascsa
Erschienen in:
Current Hepatology Reports
|
Ausgabe 2/2019
Einloggen, um Zugang zu erhalten
Abstract
Purpose of Review
We aim to review the current guidelines and emerging data and compare the pros and cons for the use of HCV-positive organs.
Recent Findings
Some recent data suggests that the use of HCV-positive livers and kidneys safely increases the organ pool, additionally reducing wait list time, healthcare costs, and mortality.
Summary
Despite this therapeutic breakthrough, the demand for organs and waitlist mortality remains high. Every year, thousands of viable hepatitis C-positive organs are discarded. The emerging data regarding transplantation of HCV-positive organs is promising; however, further research is warranted with larger samples. A literature search was conducted using PubMed, using the keywords “transplant recipients,” “hepatitis C,” “kidney transplantation,” “liver transplantation,” “direct acting antivirals,” and “pre transplant.” Only articles in the English language were included.